Condition
Asthma Atopic
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Felis Catus
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Early Phase 1 (1)
Trial Status
Recruiting1
Terminated1
Clinical Trials (2)
Research Network
Common Treatments
- Felis Catus1
- No Intervention Observational Cohort1
Active Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)1
- University of North Carolina, Chapel Hill1
- Medical University of Warsaw1
Related Conditions
- Asthma Severe Persistent Uncontrolled1